Femtech startup Fraiya raises £3.5m from RAW Ventures
This article covers the pre-seed round on 9 September 2025 for Fraiya, a UK-based femtech startup transforming pregnancy ultrasound with AI, founded by Dr Jackie Matthew and Dr Samuel Budd. The round raised £3.5m, led by RAW Ventures with participation from Cedars-Sinai Ventures.
What does Fraiya do?
FraiyaScan is a CE-marked ultrasound software that automates image acquisition, quality checks, measurements and reporting assistance. It supports clinicians during 20-week scans by providing real-time acquisition, quality control and measurement outputs.
Why is Fraiya useful?
Problem
Clinicians performing 20-week anomaly scans face time pressure, staffing gaps and variable image quality that can miss fetal abnormalities.
Solution
FraiyaScan helps by automating real-time image capture, quality checks, measurements and clinical reporting assistance during the scan. It integrates with existing ultrasound systems and supports clinicians without disrupting workflow.
How much did Fraiya raise?
Fraiya raised £3.5m in a pre-seed round, backed by RAW Ventures and Cedars-Sinai Ventures.
Who invested in Fraiya?
The following are the key investors supporting Fraiya's commercial and clinical development:
- RAW Ventures: a London-based early-stage venture firm specialising in deep-tech and AI investments across the UK and Europe.
- Cedars-Sinai Ventures: the corporate venture arm of a major US academic medical centre, focused on clinical innovation and healthtech translation.
- Syndicate of healthtech and AI-focused angel investors: bringing expertise in clinical AI, medtech commercialisation and NHS adoption to support early-stage growth.
If you're researching potential backers in this space:
- Explore our list of healthtech venture capital firms in the UK
- Browse our directory of healthtech angel investors in the UK
Who founded Fraiya?
Professor Reza Razavi is the CEO of Fraiya.
Founders are: Samuell Budd, Jackie Matthew and Alfonso Farruggia
Where is Fraiya based?
Fraiya is based in London, UK.
What sector is Fraiya in?
Fraiya operates in the medical technology sector. This sector develops technologies and devices to improve patient care. It uses AI to support clinicians during pregnancy scans.
Key trends and challenges in maternal health technology:
Need for robust clinical evidence for AI tools
Healthcare systems demand large, real-world trials to prove AI safety, effectiveness and cost-effectiveness, sometimes involving thousands.
Regulatory complexity for software as medical devices
New rules like the EU MDR increase conformity requirements and auditing for medical software and AI-based devices.
Workforce pressures and workflow integration
Staff shortages and busy clinics mean tools must fit existing workflows and save time to gain adoption.
For a deeper look at innovation in this space, see the healthtech startups in the UK.
They've invested in Fraiya
Get to know these healthtech investors
Click here for a full list of 7,589+ startup investors in the UK